To The Moon

Join our exclusive "Light up Your Investing" campaign with Tiger!Participate in our game and win fantastic prizes worth up to USD 999*!Unveil the allure of various regions as you progress through exciting game levels.But wait, there's more! Along your journey, uncover hidden rewards and unlock exclusive bonuses that will supercharge your investing game!Not only will you gain valuable knowledge and insights, but you'll also compete with fellow investors for the top spot on our leaderboard!Invite your friends and embark on this epic investing adventure together! Let's light up the world of investing with Tiger!Don't miss out on this limited-time opportunity!Campaign period: 6th June to 27th June. *T&Cs apply.👉 Click here to start play

🐰🌷 Hop into the Easter spirit and join our "Tiger's Egg Hunting" game! 🎉Stand to win free Disney stocks and a USD 120 cash voucher!🎁🌟Our interactive Easter game is open to Tigers, and it's so easy to play! Simply jump and catch the egg, and you could be a lucky winner. 🐇That's not all. You can also invite your friends to join in the fun to earn more points. Plus, you can challenge your friends for a race up the leaderboard. Let's fly to the moon together!Don't miss out on this egg-citing opportunity to win BIG! Join the game now and hop on your way to victory. 🥳🐣Join our Easter campaign now

投資界3月7日消息，諾一邁爾（蘇州）醫學科技有限公司近日宣佈完成數億元B輪融資，由蘇高新金控領投，君茂資本、鼎暉投資、匯鼎投資、翊翎資本、博雅君子蘭等投資機構跟投。本輪融資主要用於組織工程領域多個創新醫療器械產品的臨牀試驗，以及多個產品管線國際化戰略的實施。 諾一邁爾成立於2017年3月，是研發和生產“實現人體組織修復和器官再造”的再生型植入醫療器械的創新型企業。成立6年以來，諾一邁爾致力於產品與技術國內首創和國際領先，與德國弗萊堡大學等科研院所深度合作，掌握了前端原材料設計開發和關鍵工藝製備技術，實現了高端核心裝備的國產化，形成了自主知識產權，打破了國外技術壁壘。 通過國內外技術的引進與高端裝備的自主創新，諾一邁爾的產品線涵蓋了靜電紡、3D打印、化學合成等組織工程領域的關鍵技術路線，覆蓋了膜、骨、膠、劑等豐富的產品形態，延伸到口腔、眼科、耳鼻喉、外科、生殖醫學、運動醫學等多個臨牀科室，是國內再生醫學與組織工程領域賽道齊全、技術先進的綜合方案提供者之一。 諾一邁爾相繼入選國家外國專家項目計劃、江蘇省雙創人才、江蘇省外專百人、江蘇省重點研發計劃以及山東省外專雙百團隊，多次獲得中國創新創業大賽以及“創業江蘇”“贏在蘇州”等創新創業賽事重要獎項，連續入圍“中國潛在獨角獸企業”“江蘇省潛在獨角獸企業”“蘇南國家自主創新示範區潛在獨角獸企業”和“蘇州市獨角獸培育企業”等獨角獸評選榜單。 諾一邁爾下設蘇州、濰坊、太倉三個研發生產基地，北京醫學中心和德國弗萊堡海外實驗室，形成了“3+1+1”的研發創新架構。成立至今，“明膠-聚己內酯分層牙齦修復膜”“鼻腔填充海綿”等高端醫療器械產品相繼獲准進入創新醫療器械特別審查程序。 目前，諾一邁爾正在研發關節軟骨再生產品，致力於促進真正的透明軟骨及其軟骨下骨再生，無需使用細胞、生長因子或其他藥物；新一代可降解血管移植物產品，適用於慢性腎臟病透析患者，

【Does The Tesla Semi Live Up To The Hype?】Five years after Elon Musk first announced the Tesla Semi, it’s finally hitting roads. CNBC visited Pepsi’s Frito-Lay facility in Modesto, California, where it is using the new electric trucks, to see whether the Semis live up to the hype. $Tesla Motors(TSLA)$

"Buy the rumor🗣🗣, sell the news📰” is a trading strategy that can be used by traders eyeing short-term profits. ✅ In this strategy, traders buy a security based on speculation about an upcoming 📰 event & sell the security when that 📰 is announced. ❌ Disadvantages of the strategy include lack of accuracy & potential loss of opportunity on decisions not made quickly enough💸💸💸 ➡️ A common example of “Buy the 🗣🗣, sell the 🗞🗞🗞” in the stock market is trading based on the expectation of a company's quarterly earnings report. Perhaps there's a rumor that a company is expected to provide more revenue to shareholders than previously thought. In that case, traders will buy the stock quickly to take advantage of increased dividends or stock prices. Once the company has its earnings call or mak

🌈🌈🌈My Favourite Singapore Consumer Defensive Stock is $SHENG SIONG GROUP LTD(OV8.SI)$ With high inflation here, Sheng Siong will be resilient and impervious to economic cycles. Sheng Siong is the 3rd largest supermarket chain in Singapore with more than 65 locations and 4 supermarkets in China with the 5th opening in 2nd quarter 2023. Sheng Siong represents value for money to many Singaporeans especially the housewives. Sheng Siong's gross profit margin was 29.4% for 3Q FY 2022 compared to 29% in 3Q FY 2021. Its revenue declined by 4.2% year on year to SGD 333.5 million due to the Covid 19 measures in place and the closure of Jurong Fishery Port for 2 weeks in July 20

Previously, the Singapore Tourism Board stated that with the increase in the number of flights and China's resumption of outbound tourism, the recovery of Singapore's tourism industry will accelerate."It is expected that the number of international tourists visiting Singapore will reach 12 million to 14 million in 2023, returning to 75% before the epidemic In 2019, the number of inbound tourists from Singapore totaled 19.12 million.”According to recent data provided by China Aviation Travel, since the restart of the outbound and group tour pilot program on February 6, 2022, the number of inbound and outbound civil aviation passengers of China’s domestic airlines has exceeded 276,000, an increase of nearly 4.4 times compared with the same period last year. Shanghai, Guangzhou, Beijing, Xiam